Tag: antivirals market size

Uncover key drivers, emerging technologies, and competitive movements shaping the serum market from 2025–2034 with trusted insights from The Business Research Company

What Is The Projected Valuation Of The Serum Market In The Period 2029-2034?

The antivirals market has experienced robust expansion over recent years. This market is projected to expand from $106.64 billion in 2024 to $114.4 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 7.3%. Factors contributing to its historical growth include viral disease prevalence, rising public health concerns, patent expirations, and various government initiatives.

The antivirals market is projected to experience robust expansion over the coming years, with its size forecast to reach $151.54 billion by 2029, achieving a compound annual growth rate (CAGR) of 7.3%. Factors contributing to this anticipated growth include the emergence of new viral threats and widespread global health initiatives. Key trends shaping the market during this period encompass technological advancements, the rise of telemedicine and digital health solutions, and the increasing adoption of personalized medicine.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2437&type=smp

What Strategic Drivers Are Accelerating The Serum Market Expansion?

The rising occurrence of influenza is projected to boost the expansion of the antiviral market moving forward. Influenza, known also as the flu, is a very contagious viral respiratory infection caused by influenza viruses that impact the nose, throat, and lungs. Antivirals serve in the treatment of influenza, designed to stop the replication and spread of these viruses within the body. For example, in October 2022, the Centers for Disease Control and Prevention, a US-based health agency, reported that during the 2021-2022 season, there were 9 million flu illnesses, 4 million flu-related medical visits, 100,000 flu-related hospitalizations, and 5,000 flu deaths. Thus, the increasing incidence of influenza is a primary force behind the growth of the antiviral market.

What Is The Detailed Segment Distribution Of The Serum Market?

The antivirals market covered in this report is segmented –

1) By Type: Branded, Generic

2) By Drug Class: DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Other Drug classes

3) By Application: HIV, Hepatitis, Herpes, Influenza, Other Applications

Subsegments:

1) By Branded: Antivirals For HIV Or AIDS, Antivirals For Hepatitis, Antivirals For Influenza, Antivirals For Herpes Simplex Virus (HSV)

2) By Generic: Generic HIV Or AIDS Antivirals, Generic Hepatitis Antivirals, Generic Influenza Antivirals, Generic Herpes Simplex Virus (HSV) Antivirals

How Are Global Trends Impacting The Development Of The Serum Market?

Leading companies in the antiviral market are focusing on developing innovative treatments, such as oral antiviral medications, to improve patient adherence, increase accessibility, reduce healthcare costs, and provide more convenient and effective options for managing viral infections. Oral antiviral treatment refers to medicines taken orally to treat viral infections. These treatments function by inhibiting viruses from replicating or spreading within the body, which helps to lessen the infection’s severity and duration. For instance, in May 2023, Pfizer, a US-based company providing pharmaceuticals, announced the approval of Paxlovid by the Food and Drug Administration, a US-based government agency, designating it as the first oral antiviral treatment for COVID-19 in adults. This approval is particularly significant as it offers a new therapeutic choice for managing COVID-19, especially as the pandemic transitions towards an endemic phase. Paxlovid is specifically indicated for adults with mild-to-moderate COVID-19 who are at high risk for progression to severe disease, including hospitalization or death.

Who Are The Major Stakeholders Operating In The Serum Market?

Major companies operating in the antivirals market include AbbVie Inc., Bristol-Myers-Squibb Co., Chemical Industrial & Pharmaceutical Laboratories Ltd., F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson & Johnson Services Ltd., Merck & Co. Inc., Dr. Reddy’s Laboratories Ltd., AstraZeneca plc, Aurobindo Pharma Ltd., Abbott Laboratories, Schering-Plough Corporation, Pfizer Inc., Sanofi-Synthélabo Ltd., Regeneron Pharmaceuticals Inc., Inovio Pharmaceuticals Inc., Novavax Inc., BioCryst Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Argos Distributors Limited, AVI Biopharma International Ltd., Moderna Inc., BioNTech SE, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Biogen Inc., Genentech USA Inc., Vertex Pharmaceuticals Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report

Which Region Is Projected To Achieve The Fastest Growth In The Serum Market?

North America was the largest region in the anti-viral drug therapy market in 2024. The Middle East is expected to be the fastest-growing region in the antivirals market during the forecast period. The regions covered in the antivirals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=2437&type=smp

Browse Through More Reports Similar to the Global Serum Market 2025, By The Business Research Company

Anti Infective Drugs Market 2025

https://www.thebusinessresearchcompany.com/report/anti-infective-drugs-market

Hospital Acquired Infections Testing Kits Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hospital-acquired-infections-testing-kits-global-market-report

Anti Viral Drug Therapy Market 2025

https://www.thebusinessresearchcompany.com/report/anti-viral-drug-therapy-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Antivirals Industry In 2025?

The antivirals market has experienced significant growth in recent years. It is anticipated to expand from $106.64 billion in 2024 to $114.4 billion in 2025, achieving a compound annual growth rate (CAGR) of 7.3%. The expansion observed historically can be attributed to factors such as the prevalence of viral diseases, public health concerns, patent expirations, and various government initiatives.

The antivirals market is projected to experience substantial expansion over the coming years. Its size is predicted to reach $151.54 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.3%. This anticipated growth is primarily driven by factors such as emerging viral threats and global health initiatives. Key trends anticipated during this period encompass technological advances, the rise of telemedicine and digital health solutions, and personalized medicine approaches.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2437&type=smp

What Are The Top Growth Drivers Impacting The Antivirals Market Outlook?

The growing incidence of influenza is projected to propel the antiviral market’s expansion. Influenza, often referred to as the flu, constitutes a highly transmissible viral respiratory infection, brought on by influenza viruses that impact the nose, throat, and lungs. Antivirals are utilized to treat influenza, functioning to inhibit the replication and internal spread of influenza viruses. For example, in October 2022, the Centers for Disease Control and Prevention, a US-based health agency, reported 9 million flu illnesses, 4 million flu-related medical visits, 100,000 flu-related hospitalizations, and 5,000 flu deaths during the 2021-2022 season. Thus, the rising prevalence of influenza is directly contributing to the growth of the antiviral market.

What Are The Key Segments In The Antivirals Market?

The antivirals market covered in this report is segmented –

1) By Type: Branded, Generic

2) By Drug Class: DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Other Drug classes

3) By Application: HIV, Hepatitis, Herpes, Influenza, Other Applications

Subsegments:

1) By Branded: Antivirals For HIV Or AIDS, Antivirals For Hepatitis, Antivirals For Influenza, Antivirals For Herpes Simplex Virus (HSV)

2) By Generic: Generic HIV Or AIDS Antivirals, Generic Hepatitis Antivirals, Generic Influenza Antivirals, Generic Herpes Simplex Virus (HSV) Antivirals

Which Market Trends Are Creating New Opportunities In The Antivirals Industry?

Leading companies within the antiviral market are concentrating on developing innovative remedies like oral antiviral treatments. This focus aims to enhance patient compliance, broaden accessibility, reduce healthcare expenses, and offer more convenient and effective methods for managing viral infections. Oral antiviral treatment refers to medications taken by mouth specifically to treat viral infections. These treatments function by inhibiting viruses from replicating or spreading within the body, thereby helping to diminish the infection’s severity and duration. For instance, in May 2023, Pfizer, a US-based pharmaceutical company, announced that Paxlovid had received approval, establishing it as the first oral antiviral treatment for COVID-19 in adults by the Food and Drug Administration, a US-based government agency. This approval is especially significant as it presents a new therapeutic option for handling COVID-19, particularly in a period where the pandemic is transitioning toward an endemic phase. Paxlovid is specifically indicated for adults with mild-to-moderate COVID-19 who are at high risk for progression to severe disease, including hospitalization or death.

Who Are The Core Companies Influencing The Antivirals Market Landscape?

Major companies operating in the antivirals market include AbbVie Inc., Bristol-Myers-Squibb Co., Chemical Industrial & Pharmaceutical Laboratories Ltd., F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson & Johnson Services Ltd., Merck & Co. Inc., Dr. Reddy’s Laboratories Ltd., AstraZeneca plc, Aurobindo Pharma Ltd., Abbott Laboratories, Schering-Plough Corporation, Pfizer Inc., Sanofi-Synthélabo Ltd., Regeneron Pharmaceuticals Inc., Inovio Pharmaceuticals Inc., Novavax Inc., BioCryst Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Argos Distributors Limited, AVI Biopharma International Ltd., Moderna Inc., BioNTech SE, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Biogen Inc., Genentech USA Inc., Vertex Pharmaceuticals Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report

How Is Antivirals Market Demand Varying Across Different Regions?

North America was the largest region in the anti-viral drug therapy market in 2024. The Middle East is expected to be the fastest-growing region in the antivirals market during the forecast period. The regions covered in the antivirals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Antivirals Market Report:

https://www.thebusinessresearchcompany.com/customise?id=2437&type=smp

Browse Through More Reports Similar to the Global Antivirals Market 2025, By The Business Research Company

Anti Infective Drugs Market 2025

https://www.thebusinessresearchcompany.com/report/anti-infective-drugs-market

Hospital Acquired Infections Testing Kits Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hospital-acquired-infections-testing-kits-global-market-report

Anti Viral Drug Therapy Market 2025

https://www.thebusinessresearchcompany.com/report/anti-viral-drug-therapy-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Is The Present And Forecasted Size Of The Antivirals Market?

There has been significant expansion of the antivirals market size in past times. Its value is predicted to rise from $106.64 billion in 2024 to $114.4 billion in 2025, registering a compound annual growth rate (CAGR) of 7.3%. The historical period’s growth can be linked to the prevalence of viral diseases, public health worries, lapses in patent rights, and efforts taken by the government.

Over the upcoming years, the antivirals market is anticipated to witness robust growth, expanding to “$151.54 billion by 2029 with a compound annual growth rate (CAGR) of 7.3%. The increase predicted for the forecast period is credited to the rise of new viral threats and worldwide health initiatives. The forecast period is set to be marked by significant trends such as technological progression, the rise of telemedicine and digital health, and the growth of personalized medicine.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2437&type=smp

Which Key Factors Are Fueling Growth In The Antivirals Market?

The rise in influenza cases is expected to boost the antiviral market’s expansion. Influenza, commonly known as the flu, is an extremely infectious viral respiratory disorder caused by the influenza virus, which impacts the nose, throat, and lungs. Antivirals, intended to prevent the growth and dissemination of the influenza virus inside the body, are utilized to treat this disease. For example, the US-based health agency, the Centers for Disease Control and Prevention, reported in October 2022 that, during the 2021-2022 season, there were 9 million instances of flu illnesses, 4 million flu-associated medical consultations, 100,000 flu-related hospitalizations, and 5,000 flu fatalities. Consequently, the escalating rate of influenza is fueling the antiviral market’s growth.

What Are The Key Segment Trends Observed In The Antivirals Market?

The antivirals market covered in this report is segmented –

1) By Type: Branded, Generic

2) By Drug Class: DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Other Drug classes

3) By Application: HIV, Hepatitis, Herpes, Influenza, Other Applications

Subsegments:

1) By Branded: Antivirals For HIV Or AIDS, Antivirals For Hepatitis, Antivirals For Influenza, Antivirals For Herpes Simplex Virus (HSV)

2) By Generic: Generic HIV Or AIDS Antivirals, Generic Hepatitis Antivirals, Generic Influenza Antivirals, Generic Herpes Simplex Virus (HSV) Antivirals

Which Disruptive Trends Are Driving Change Across The Antivirals Market?

Key players in the antiviral market are shifting their focus towards the creation of novel therapies such as oral antiviral treatment. This pivot aims at enhancing patient adherence, improving accessibility, lowering healthcare expenses, and offering more suitable and effective alternatives for the management of viral infections. Oral antiviral therapy means medication taken orally to combat viral infections. These treatments function by obstructing the replication or dissemination of viruses within the body, thus minimizing the intensity and duration of the infection. For example, in May 2023, Pfizer, a pharmaceutical company based in the United States, announced the approval of Paxlovid, the first-ever oral antiviral treatment for adults with COVID-19, approved by the Food and Drug Administration, a U.S. government agency. This approval carries noteworthy significance as it furnishes a fresh therapeutic alternative for managing COVID-19, particularly in a scenario where the pandemic is evolving into an endemic phase. Paxlovid is specifically designated for adults with mild to moderate COVID-19 who are at an elevated risk of escalating to a severe stage, including hospitalization or death.

Who Are The Major Stakeholders Operating In The Antivirals Market?

Major companies operating in the antivirals market include AbbVie Inc., Bristol-Myers-Squibb Co., Chemical Industrial & Pharmaceutical Laboratories Ltd., F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson & Johnson Services Ltd., Merck & Co. Inc., Dr. Reddy’s Laboratories Ltd., AstraZeneca plc, Aurobindo Pharma Ltd., Abbott Laboratories, Schering-Plough Corporation, Pfizer Inc., Sanofi-Synthélabo Ltd., Regeneron Pharmaceuticals Inc., Inovio Pharmaceuticals Inc., Novavax Inc., BioCryst Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Argos Distributors Limited, AVI Biopharma International Ltd., Moderna Inc., BioNTech SE, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Biogen Inc., Genentech USA Inc., Vertex Pharmaceuticals Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report

What Regional Factors Are Accelerating Growth In The Antivirals Market?

North America was the largest region in the anti-viral drug therapy market in 2024. The Middle East is expected to be the fastest-growing region in the antivirals market during the forecast period. The regions covered in the antivirals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=2437&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only._x000D_

_x000D_

#What Are the Latest Market Insights for the Serum Industry?#_x000D_

In recent years, the antivirals market has experienced substantial expansion. It is projected to escalate from $106.64 billion in 2024 to $114.4 billion in 2025, marking a compound annual growth rate (CAGR) of 7.3%. Several factors such as the prevalence of viral diseases, public health issues, expiration of patents, and government incentives contributed to this growth during the historic period._x000D_

_x000D_

The market for antivirals is forecasted to experience robust expansion in the upcoming years, with projections estimating it to reach “$151.54 billion in 2029 with a compound annual growth rate (CAGR) of 7.3%. The impetus for this growth in the projected period can be linked to the advent of new viral threats and international health campaigns. The period also expects to witness significant trends such as technological progression, the rise of telemedicine and digital health, as well as the growth of personalized medicine._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=2437&type=smp_x000D_

_x000D_

#What Forces Are Driving The Growth Of The Serum Industry?#_x000D_

An increased understanding of skin problems related to aging is anticipated to drive the serum market’s expansion. Skin conditions typically faced by an aging demographic, including wrinkles and facial movement lines, are referred to as age-related skin issues. Serums are effective in addressing these age-related skin concerns, such as dull skin, hyperpigmentation, dehydration, wrinkles, and sagging skin. They also help in balancing skin color, brightening skin, diminishing visible imperfections, and providing nourishment. For instance, data from Melanoma UK, a UK-based patient support and advocacy group, suggests that by 2025, melanoma skin cancer cases are expected to surge by 9% to a total of 19,513. Also, the fatalities as a result of this disease are likely to increase 13% to 3,119. By 2040, a staggering 22,886 individuals are expected to be diagnosed with melanoma skin cancer. Therefore, the escalating consciousness about age-related skin issues is fueling the boom in the serum market._x000D_

_x000D_

_x000D_

The antivirals market covered in this report is segmented – _x000D_

_x000D_

1) By Type: Branded, Generic_x000D_

2) By Drug Class: DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Other Drug classes _x000D_

3) By Application: HIV, Hepatitis, Herpes, Influenza, Other Applications_x000D_

_x000D_

Subsegments:_x000D_

1) By Branded: Antivirals For HIV Or AIDS, Antivirals For Hepatitis, Antivirals For Influenza, Antivirals For Herpes Simplex Virus (HSV) _x000D_

2) By Generic: Generic HIV Or AIDS Antivirals, Generic Hepatitis Antivirals, Generic Influenza Antivirals, Generic Herpes Simplex Virus (HSV) Antivirals_x000D_

_x000D_

#How Are Key Trends Driving Expansion In The Serum Industry?#_x000D_

Leading businesses in the antiviral market are concentrating their efforts on creating novel therapies, such as oral antiviral treatments, aimed at enhancing patient adherence, improving accessibility, curbing healthcare expenditure, and providing more effective and convenient solutions for viral infection management. Oral antiviral treatments, which are medication taken orally to combat viral infections, function by hindering the replication or spread of viruses within the human body, hence reducing the infection’s intensity and period. For example, Pfizer, a US pharmaceutical company, announced the Food and Drug Administration’s endorsement of Paxlovid in May 2023. This event is noteworthy because Paxlovid, the first-ever orally administered antiviral treatment for adult COVID-19 patients, introduces a fresh approach to COVID-19 management, especially as the world prepares for the pandemic’s potential transition into an endemic phase. Paxlovid is particularly designed for adults with a mild to moderate case of COVID-19 and who are at a high risk of the disease worsening to a severe state, potentially leading to hospitalization or even death._x000D_

_x000D_

#Who Are The Primary Players Operating Across The Global Serum Market?#_x000D_

Major companies operating in the antivirals market include AbbVie Inc., Bristol-Myers-Squibb Co., Chemical Industrial & Pharmaceutical Laboratories Ltd., F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson & Johnson Services Ltd., Merck & Co. Inc., Dr. Reddy’s Laboratories Ltd., AstraZeneca plc, Aurobindo Pharma Ltd., Abbott Laboratories, Schering-Plough Corporation, Pfizer Inc., Sanofi-Synthélabo Ltd., Regeneron Pharmaceuticals Inc., Inovio Pharmaceuticals Inc., Novavax Inc., BioCryst Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Argos Distributors Limited, AVI Biopharma International Ltd., Moderna Inc., BioNTech SE, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Biogen Inc., Genentech USA Inc., Vertex Pharmaceuticals Inc._x000D_

_x000D_

_x000D_

https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report_x000D_

_x000D_

#Which Region Offers The Most Growth Potential For The Serum Market Through 2029?#_x000D_

North America was the largest region in the anti-viral drug therapy market in 2024. The Middle East is expected to be the fastest-growing region in the antivirals market during the forecast period. The regions covered in the antivirals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=2437&type=smp_x000D_

_x000D_

#About The Business Research Company:#_x000D_

_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Antivirals Market Size Shifted, And What Is the Outlook Through 2034?

The dimension of the antivirals market has notably expanded in the last few years. It’s projected to escalate from $106.64 billion in 2024 to $114.4 billion in 2025, with a compound annual growth rate (CAGR) of 7.3%. Several factors can explain the growth in this historic period – factors like the prevalence of viral diseases, concerns about public health, expiring patents, and government actions.

In the forthcoming years, the antivirals market size is projected to experience robust growth. It is anticipated to reach a value of $151.54 billion by 2029, with a Compound Annual Growth Rate (CAGR) of 7.3%. This expansion during the forecast period can be linked to the advent of novel viral threats and worldwide health initiatives. Technological advancements, the emergence of telemedicine and digital health, as well as personalized medicine are the key trends set to dominate the forecast period.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2437&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Antivirals Market?

The growth of the antiviral market is expected to be driven by the rising occurrence of influenza. Often referred to as flu, influenza is an extremely transmittable viral respiratory infection instigated by influenza viruses affecting the nose, throat, and lungs. Antivirals, which are created to disrupt the proliferation and diffusion of these viruses within the human body, offer a treatment option for influenza. For example, the US health agency, Centers for Disease Control and Prevention, reported in October 2022, that there were 9 million cases of flu illnesses, 4 million medical consultations related to the flu, 100,000 hospitalizations due to flu, and 5,000 flu fatalities during the 2021-2022 season. As a result, the escalating incidence of influenza is fueling the expansion of the antiviral market.

Which Key Market Segments Comprise the Antivirals Market and Drive Its Revenue Growth?

The antivirals market covered in this report is segmented –

1) By Type: Branded, Generic

2) By Drug Class: DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Other Drug classes

3) By Application: HIV, Hepatitis, Herpes, Influenza, Other Applications

Subsegments:

1) By Branded: Antivirals For HIV Or AIDS, Antivirals For Hepatitis, Antivirals For Influenza, Antivirals For Herpes Simplex Virus (HSV)

2) By Generic: Generic HIV Or AIDS Antivirals, Generic Hepatitis Antivirals, Generic Influenza Antivirals, Generic Herpes Simplex Virus (HSV) Antivirals

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=2437&type=smp

Which Areas Are Leading Regions in the Antivirals Market Expansion Across the Globe?

North America was the largest region in the anti-viral drug therapy market in 2024. The Middle East is expected to be the fastest-growing region in the antivirals market during the forecast period. The regions covered in the antivirals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Strategic Trends Steering theAntivirals Market Direction?

Leading firms in the antiviral market are prioritizing the development of innovative therapies like oral antiviral interventions to enhance patient adherence, increase accessibility, lower healthcare expenses, and deliver more efficient and user-friendly solutions for managing viral infections. Oral antiviral therapy involves the use of medication consumed orally to combat viral infections. These therapeutic modalities function by obstructing the capacity of viruses to multiply or disseminate within the organism, thereby curtailing the severity and duration of the infection. For example, Pfizer, a US pharmaceutical company, announced in May 2023 its approval for Paxlovid, heralding it as the inaugural oral antiviral remedy for COVID-19 in adults, sanctioned by the Food and Drug Administration, a US government agency. This endorsement carries immense importance as it offers a novel management strategy for COVID-19, particularly as the pandemic appears to be shifting to an endemic stage. Paxlovid is expressly meant for adults with mild-to-moderate COVID-19 who have a high probability of escalating to severe disease, encompassing hospitalization or mortality.

View the full report here:

https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report

How Is the Antivirals Market Conceptually Defined?

Antivirals are medications designed to treat viral infections by inhibiting the replication of viruses within the host’s cells. Unlike antibiotics, which target bacteria, antivirals are specifically used to combat viruses such as the flu, HIV, or hepatitis. They work by interfering with various stages of a virus’s lifecycle, helping to reduce the severity and duration of an infection.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2437

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Projected Market Size and Growth Rates for the Antivirals Market From 2025 To 2029?

In recent times, the antivirals market has witnessed substantial growth. The market, which is projected to escalate from $106.13 billion in 2024 to $114.7 billion in 2025, predicts a compound annual growth rate (CAGR) of 8.1%. Factors such as the prevalence of viral diseases, public health worries, the expiration of patents, and government interventions are reasons behind the growth witnessed in the historic period.

What Is the Projected Market Size of the Antivirals Market?

The size of the antivirals market is predicted to experience robust expansion in the forthcoming years. The market is projected to rise to $153.67 billion by 2029 with an annual compound growth rate (CAGR) of 7.6%. The predicted increase during the forecast period is due to the emergence of new viral risks and global health initiatives. Innovations in technology, telemedicine, digital health, and personalized medicine are some of the key trends expected to emerge during this period.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2437&type=smp

Who are the Major Competitors in the Antivirals Market Outlook?

Major companies operating in the antivirals market include AbbVie Inc., Bristol-Myers-Squibb Co., Chemical Industrial & Pharmaceutical Laboratories Ltd., F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson & Johnson Services Ltd., Merck & Co. Inc., Dr. Reddy’s Laboratories Ltd., AstraZeneca plc, Aurobindo Pharma Ltd., Abbott Laboratories, Schering-Plough Corporation, Pfizer Inc., Sanofi-Synthélabo Ltd., Regeneron Pharmaceuticals Inc., Inovio Pharmaceuticals Inc., Novavax Inc., BioCryst Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Argos Distributors Limited, AVI Biopharma International Ltd., Moderna Inc., BioNTech SE, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Biogen Inc., Genentech USA Inc., Vertex Pharmaceuticals Inc.

What Is Fueling Growth in the Antivirals Market?

The anticipated escalation of the antiviral market is largely due to the growing prevalence of influenza. Commonly referred to as flu, influenza is an easily transmissible respiratory infection instigated by influenza viruses impacting the nose, throat, and lungs. Antivirals, which inhibit the multiplication and dissemination of influenza viruses within the organism, are prescribed for treating this illness. For example, The Centers for Disease Control and Prevention, an American health organization, reported in October 2022 that during the 2021-2022 period, there were 9 million instances of flu illnesses, 4 million flu-related medical appointments, 100,000 flu-related hospital admissions, and 5,000 flu fatalities. Hence, the rising occurrence of influenza is spurring the expansion of the antiviral market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=2437&type=smp

Which Antivirals Market Segments Are Growing the Fastest?

The antivirals market covered in this report is segmented –

1) By Type: Branded, Generic

2) By Drug Class: DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Other Drug classes

3) By Application: HIV, Hepatitis, Herpes, Influenza, Other Applications

Subsegments:

1) By Branded: Antivirals For HIV Or AIDS, Antivirals For Hepatitis, Antivirals For Influenza, Antivirals For Herpes Simplex Virus (HSV)

2) By Generic: Generic HIV Or AIDS Antivirals, Generic Hepatitis Antivirals, Generic Influenza Antivirals, Generic Herpes Simplex Virus (HSV) Antivirals

Which Industry Trends Are Shaping the Future of the Antivirals Market?

Leading corporations in the antiviral market are concentrating on the development of innovative solutions like oral antiviral treatments to improve patient adherence, enhance reachability, cut healthcare expenses, and offer more efficient and easy-to-use alternatives for controlling viral diseases. Oral antiviral treatment comprises medication consumed orally to counteract viral infections. They function by restricting the replication and spread of viruses in the body, thereby minimizing the severity and span of the infection. For example, Pfizer, a pharmaceutical firm based in the US, announced in May 2023, the sanction of Paxlovid, establishing it as the first oral antiviral treatment for COVID-19 in adults, approved by the Food and Drug Administration, a government agency in the US. This approval holds immense significance as it introduces a new method for managing COVID-19, especially during the phase where the pandemic is evolving into an endemic stage. Paxlovid is specifically designed for adults experiencing mild-to-moderate COVID-19 and who are at an elevated risk of escalating to severe disease, including hospitalization or death.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report

Which Countries Are Leading the Antivirals Market?

North America was the largest region in the anti-viral drug therapy market in 2023. The Middle East is expected to be the fastest-growing region in the antivirals market during the forecast period. The regions covered in the antivirals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2437

This Report Delivers Insight On:

1. How big is the antivirals market, and how is it changing globally?

2. Who are the major companies in the antivirals market, and how are they performing?

3. What are the key opportunities and risks in the antivirals market right now?

4. Which products or customer segments are growing the most in the antivirals market?

5. What factors are helping or slowing down the growth of the antivirals market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the antivirals industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Has The Antivirals Market Growth Evolved From 2024 To 2025, And What’s Ahead?

The scale of the antivirals market has notably increased in the past few years. The market which was valued at $106.13 billion in 2024 is projected to reach $114.7 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.1%. The growth observed in the historic period can be linked to the prevalence of viral diseases, widespread public health concerns, expiration of patents, and initiatives taken by the government.

In the coming years, the antivirals market size is projected to exhibit robust growth, and is anticipated to expand to a value of $153.67 billion in 2029, with a Compound Annual Growth Rate (CAGR) of 7.6%. The ascending trajectory over the forecast period is credited to burgeoning viral risks and worldwide health endeavors. Prominent trends within the forecasting timeframe include technological progress, the rise of telemedicine and digital health, as well as the adoption of personalized medicine.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2437&type=smp

What Are the Core Growth Drivers Propelling the Antivirals Market Forward?

The uptick in flu cases is expected to fuel the rise of the antiviral market. Flu, or influenza, is an extremely contagious infection of the respiratory system, brought on by influenza viruses which infect the lungs, throat and nose. Antivirals are implemented in flu treatment, created to restrict the multiplication and dispersion of these viruses within the host body. For example, the US health agency, the Centers for Disease Control and Prevention, reported in October 2022 that there were 9 million instances of flu illnesses, 4 million medical appointments related to the flu, 100,000 flu-related hospital admissions and 5,000 fatalities caused by the flu in the 2021-2022 season. Consequently, the rising occurrence of influenza is pushing the antiviral market’s expansion.

What Segment Types Define the Antivirals Market Structure?

The antivirals market covered in this report is segmented –

1) By Type: Branded, Generic

2) By Drug Class: DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Other Drug classes

3) By Application: HIV, Hepatitis, Herpes, Influenza, Other Applications

Subsegments:

1) By Branded: Antivirals For HIV Or AIDS, Antivirals For Hepatitis, Antivirals For Influenza, Antivirals For Herpes Simplex Virus (HSV)

2) By Generic: Generic HIV Or AIDS Antivirals, Generic Hepatitis Antivirals, Generic Influenza Antivirals, Generic Herpes Simplex Virus (HSV) Antivirals

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=2437&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Antivirals Market?

North America was the largest region in the anti-viral drug therapy market in 2023. The Middle East is expected to be the fastest-growing region in the antivirals market during the forecast period. The regions covered in the antivirals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Long-Term Trends Are Transforming the Competitive Landscape of the Antivirals Market?

Prominent players involved in the antiviral market are concentrating on the creation of unique therapies such as oral antiviral medication to increase patient compliance, enhance access, decrease medical expenses, and offer more user-friendly and potent alternatives for handling viral contagions. Oral antiviral treatment entails drugs that are consumed orally to manage viral diseases. This form of therapy operates by preventing the replication or proliferation of viruses within the body, thereby minimizing the intensity and length of the infection. For example, Pfizer, a pharmaceutical firm based in the United States, reported in May 2023 that the Food and Drug Administration, a US government agency, had approved Paxlovid, making it the first oral antiviral medication for adults suffering from COVID-19. This endorsement is highly relevant as it offers a novel therapeutic approach to tackle COVID-19, particularly as the pandemic is moving towards becoming an endemic. Paxlovid is specifically recommended for adults who have mild-to-moderate COVID-19 and are at a high risk of escalating to advanced illness, including hospitalization or death.

View the full report here:

https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report

What Is the Definition of the Antivirals Market?

Antivirals are medications designed to treat viral infections by inhibiting the replication of viruses within the host’s cells. Unlike antibiotics, which target bacteria, antivirals are specifically used to combat viruses such as the flu, HIV, or hepatitis. They work by interfering with various stages of a virus’s lifecycle, helping to reduce the severity and duration of an infection.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2437

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Factors Are Propelling the Market Growth of theAntivirals Market from 2025 to 2034?

The growing incidence of influenza is expected to drive further growth in the antiviral market. Influenza is a highly contagious respiratory illness that continues to affect millions worldwide each year. For example, the Centers for Disease Control and Prevention (CDC) reported that during the 2021-2022 flu season, there were 9 million flu illnesses and 100,000 hospitalizations. As such, the rising number of flu cases will contribute to increased demand for antiviral treatments.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2437&type=smp

#What is the Growth Potential of the Antivirals Market, and How Will It Perform by 2034?

The antivirals market has grown considerably in recent years. It is expected to expand from $106.13 billion in 2024 to $114.7 billion in 2025, with a CAGR of 8.1%. This expansion has been driven by the prevalence of viral infections, rising public health concerns, patent expirations, and supportive government measures.

The antivirals market is projected to experience significant growth, reaching $153.67 billion by 2029 at a CAGR of 7.6%. The expansion is driven by emerging viral threats and global health initiatives. Trends include technological advances, telemedicine, digital health, and personalized medicine.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2437

How Are Market Trends and Innovations Revolutionizing theAntivirals Industry in Recent Times?

In the antiviral market, leading companies are creating more accessible and effective treatments like oral antivirals. These solutions enhance patient convenience and lower healthcare costs. For instance, in May 2023, Pfizer received FDA approval for Paxlovid, the first oral antiviral treatment for adults with mild-to-moderate COVID-19 who are at risk of developing severe symptoms.

Which Key Market Players Are Shaping the Future and Growth of theAntivirals Market?

Major companies operating in the antivirals market include AbbVie Inc., Bristol-Myers-Squibb Co., Chemical Industrial & Pharmaceutical Laboratories Ltd., F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson & Johnson Services Ltd., Merck & Co. Inc., Dr. Reddy’s Laboratories Ltd., AstraZeneca plc, Aurobindo Pharma Ltd., Abbott Laboratories, Schering-Plough Corporation, Pfizer Inc., Sanofi-Synthélabo Ltd., Regeneron Pharmaceuticals Inc., Inovio Pharmaceuticals Inc., Novavax Inc., BioCryst Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Argos Distributors Limited, AVI Biopharma International Ltd., Moderna Inc., BioNTech SE, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Biogen Inc., Genentech USA Inc., Vertex Pharmaceuticals Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report

What Are the Core Segments of the Antivirals Market, and How Do They Contribute to Growth?

The antivirals market covered in this report is segmented –

1) By Type: Branded, Generic

2) By Drug Class: DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Other Drug classes

3) By Application: HIV, Hepatitis, Herpes, Influenza, Other Applications

Subsegments:

1) By Branded: Antivirals For HIV Or AIDS, Antivirals For Hepatitis, Antivirals For Influenza, Antivirals For Herpes Simplex Virus (HSV)

2) By Generic: Generic HIV Or AIDS Antivirals, Generic Hepatitis Antivirals, Generic Influenza Antivirals, Generic Herpes Simplex Virus (HSV) Antivirals

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=2437&type=smp

What Regions Are Dominating the Antivirals Market Growth?

North America was the largest region in the anti-viral drug therapy market in 2023. The Middle East is expected to be the fastest-growing region in the antivirals market during the forecast period. The regions covered in the antivirals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Reports Similar to the Global Antivirals Market 2025, By The Business Research Company:

Liposomal Drug Delivery Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/liposomal-drug-delivery-devices-global-market-report

COVID-19 Drug Associated APIs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/covid19-drug-associated-api-global-market-report

Hospital Acquired Infections Testing Kits Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hospital-acquired-infections-testing-kits-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How Significant is the Anticipated Growth Rate of the Antivirals Market from 2025 to 2034?

The size of the antivirals market has seen considerable growth in the past few years. The market is projected to increase from $106.13 billion in 2024 to $114.7 billion in 2025, with a compound annual growth rate (CAGR) of 8.1%. This growth during the historic period can be associated with the high occurrence of viral diseases, concerns about public health, the expiration of patents, and initiatives taken by the government.

The market size for antivirals is anticipated to experience robust expansion in the upcoming years. It’s predicted to surge to a value of $153.67 billion by 2029, with a compound annual growth rate (CAGR) of 7.6%. The projected growth over this period could be attributed to the rise in viral threats and worldwide health initiatives. Key trends for this forecast period involve advancements in technology, a shift towards telemedicine and digital health, as well as personalized medicine.

How Are the key drivers expanding the growth of the Antivirals Market?

The surge in occurrences of influenza is projected to drive the expansion of the antiviral market. Influenza, colloquially known as the flu, is a contagious viral infection that affects the respiratory system primarily the nose, throat, and lungs, caused by influenza viruses. Antivirals serve as a treatment method for influenza, designed to constrain the duplication and dissemination of the influenza virus within the human body. To illustrate, the Centers for Disease Control and Prevention, a health organization from the US, reported in October 2022, that there were 9 million flu diseases, 4 million medical appointments related to flu, 100,000 hospitalizations due to flu, and 5,000 deaths resulting from influenza during the 2021-2022 season. Hence, the escalating prevalence of influenza fosters the development of the antiviral market.

Get Your Free Sample of the Global Antivirals Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=2437&type=smp

Who Are the Dominant Players Pushing the Boundaries of the Antivirals Market?

Major companies operating in the antivirals market include AbbVie Inc., Bristol-Myers-Squibb Co., Chemical Industrial & Pharmaceutical Laboratories Ltd., F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson & Johnson Services Ltd., Merck & Co. Inc., Dr. Reddy’s Laboratories Ltd., AstraZeneca plc, Aurobindo Pharma Ltd., Abbott Laboratories, Schering-Plough Corporation, Pfizer Inc., Sanofi-Synthélabo Ltd., Regeneron Pharmaceuticals Inc., Inovio Pharmaceuticals Inc., Novavax Inc., BioCryst Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Argos Distributors Limited, AVI Biopharma International Ltd., Moderna Inc., BioNTech SE, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Biogen Inc., Genentech USA Inc., Vertex Pharmaceuticals Inc.

How Are Market Trends Revolutionizing the Antivirals Industry in Recent Times?

Key players in the antiviral market, such as Pfizer, are striving towards the development of groundbreaking therapies like oral antiviral treatment. This effort is aimed at enhancing patient comfort, promoting accessibility, lowering healthcare expenses, and offering more efficient and convenient choices for managing viral infections. Essentially, oral antiviral treatments are medications consumed orally to combat viral infections. They function by limiting the capacity of viruses to replicate or spread inside the body, thus mitigating the intensity and span of the infection. To illustrate, in May 2023, Pfizer, a prominent pharmaceutical company headquartered in the US, announced the Food and Drug Administration’s approval of Paxlovid, establishing it as the inaugural oral antiviral treatment for adult COVID-19 patients. This endorsement is particularly noteworthy as it introduces a fresh treatment alternative for managing COVID-19, particularly in a scenario where the pandemic is evolving into an endemic phase. Paxlovid is specifically prescribed for adults with mild to moderate COVID-19 who have a high likelihood of progressing to severe disease or requiring hospitalization or even leading to death.

Get Instant Access to the Global Antivirals Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report

What Are the Key Components of the Antivirals Market, and How Do Its Segments Perform?

The antivirals market covered in this report is segmented –

1) By Type: Branded, Generic

2) By Drug Class: DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Other Drug classes

3) By Application: HIV, Hepatitis, Herpes, Influenza, Other Applications

Subsegments:

1) By Branded: Antivirals For HIV Or AIDS, Antivirals For Hepatitis, Antivirals For Influenza, Antivirals For Herpes Simplex Virus (HSV)

2) By Generic: Generic HIV Or AIDS Antivirals, Generic Hepatitis Antivirals, Generic Influenza Antivirals, Generic Herpes Simplex Virus (HSV) Antivirals

Which Geographic Areas Are Influencing the Growth of the Antivirals Market?

North America was the largest region in the anti-viral drug therapy market in 2023. The Middle East is expected to be the fastest-growing region in the antivirals market during the forecast period. The regions covered in the antivirals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

How Can We Define the Antivirals Market and Its Key Components?

Antivirals are medications designed to treat viral infections by inhibiting the replication of viruses within the host’s cells. Unlike antibiotics, which target bacteria, antivirals are specifically used to combat viruses such as the flu, HIV, or hepatitis. They work by interfering with various stages of a virus’s lifecycle, helping to reduce the severity and duration of an infection.

Browse Through More Similar Reports By The Business Research Company:

Liposomal Drug Delivery Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/liposomal-drug-delivery-devices-global-market-report

COVID-19 Drug Associated APIs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/covid19-drug-associated-api-global-market-report

Hospital Acquired Infections Testing Kits Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hospital-acquired-infections-testing-kits-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: